ES2841904T3 - Anticuerpos antiacetaminofén y aductos acetaminofén-proteína - Google Patents

Anticuerpos antiacetaminofén y aductos acetaminofén-proteína Download PDF

Info

Publication number
ES2841904T3
ES2841904T3 ES15865732T ES15865732T ES2841904T3 ES 2841904 T3 ES2841904 T3 ES 2841904T3 ES 15865732 T ES15865732 T ES 15865732T ES 15865732 T ES15865732 T ES 15865732T ES 2841904 T3 ES2841904 T3 ES 2841904T3
Authority
ES
Spain
Prior art keywords
acetaminophen
amino acid
antibody
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15865732T
Other languages
English (en)
Spanish (es)
Inventor
Dean W Roberts
Laura James
Jack Hinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arkansas Childrens Hospital Research Institute Inc
BioVentures LLC
Original Assignee
Arkansas Childrens Hospital Research Institute Inc
BioVentures LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkansas Childrens Hospital Research Institute Inc, BioVentures LLC filed Critical Arkansas Childrens Hospital Research Institute Inc
Application granted granted Critical
Publication of ES2841904T3 publication Critical patent/ES2841904T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
ES15865732T 2014-12-03 2015-12-03 Anticuerpos antiacetaminofén y aductos acetaminofén-proteína Active ES2841904T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462086923P 2014-12-03 2014-12-03
PCT/US2015/063786 WO2016090163A2 (en) 2014-12-03 2015-12-03 Anti-acetaminophen antibodies and acetaminophen protein adducts

Publications (1)

Publication Number Publication Date
ES2841904T3 true ES2841904T3 (es) 2021-07-12

Family

ID=56092671

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15865732T Active ES2841904T3 (es) 2014-12-03 2015-12-03 Anticuerpos antiacetaminofén y aductos acetaminofén-proteína

Country Status (6)

Country Link
US (2) US10570216B2 (enExample)
EP (1) EP3227681B1 (enExample)
JP (2) JP6785239B2 (enExample)
AU (2) AU2015358373B2 (enExample)
ES (1) ES2841904T3 (enExample)
WO (1) WO2016090163A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3104849B1 (en) 2014-02-14 2019-08-28 BioVentures, LLC Acetaminophen protein adducts and methods of use thereof
US10570216B2 (en) 2014-12-03 2020-02-25 Bioventures, Llc Anti-acetaminophen antibodies and acetaminophen protein adducts
CN112980808B (zh) * 2019-12-12 2024-10-29 深圳迈瑞生物医疗电子股份有限公司 尿酸酶、及其制备方法和用途
CN113248596B (zh) * 2021-04-15 2022-12-16 华南农业大学 一种可同时检测对乙酰氨基酚和非那西丁的人工抗原、抗体及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424150A (en) 1982-04-02 1984-01-03 Syva Company Acetaminophen analogs, antigens, and antibodies
US5103021A (en) 1982-04-02 1992-04-07 Syntex (U.S.A.) Inc. Acetaminophen analogs, antigens, and antibodies
EP1248112A3 (en) 1987-04-27 2004-08-25 Inverness Medical Switzerland GmbH Immunochromatographic specific binding assay device
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
ES2091301T3 (es) 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
US6905882B2 (en) 1992-05-21 2005-06-14 Biosite, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5747352A (en) 1994-05-23 1998-05-05 Beckman Instruments, Inc. Reagents and methods for the rapid and quantitative assay of pharmacological agents
US5620890A (en) 1995-03-14 1997-04-15 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to hygromycin B and the method of making the same
US20040185040A1 (en) 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
WO2009097133A2 (en) * 2008-01-30 2009-08-06 Monsanto Technology, Llc Transgenic plants with enhanced agronomic traits
WO2009099580A2 (en) 2008-02-05 2009-08-13 Monsanto Technology, Llc Isolated novel nucleic acid and protein molecules from soy and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
US20090263839A1 (en) * 2008-04-21 2009-10-22 Board Of Trustees Of The University Of Arkansas Acetaminophen-protein adduct assay device and method
WO2010083179A2 (en) * 2009-01-16 2010-07-22 Monsanto Technology Llc Isolated novel nucleic acid and protein molecules from soybeans and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
EA032728B1 (ru) 2009-08-19 2019-07-31 Мерк Патент Гмбх Антитела для выявления комплексов интегрина в ffpe материале
DK2536758T3 (en) * 2010-02-16 2019-03-04 Oesterreichische Akademie Der Wss ANTI-HPV E7 ANTIBODIES
US20110214205A1 (en) 2010-02-26 2011-09-01 Monsanto Technology Llc. Isolated Novel Nucleic Acid and Protein Molecules from Foxtail Millet and Methods of Using Those Molecules to Generate Transgenic Plants with Enhanced Agronomic Traits
CN103688176A (zh) 2011-04-29 2014-03-26 细胞基因公司 利用cereblon作为预报因子治疗癌和炎性疾病的方法
LT2841575T (lt) * 2012-04-27 2019-10-10 Millennium Pharmaceuticals, Inc. Antikūno molekulės, nukreiptos prieš gcc, ir jų panaudojimas nustatant jautrumą į gcc nukreiptai terapijai
EP3104849B1 (en) 2014-02-14 2019-08-28 BioVentures, LLC Acetaminophen protein adducts and methods of use thereof
US10570216B2 (en) 2014-12-03 2020-02-25 Bioventures, Llc Anti-acetaminophen antibodies and acetaminophen protein adducts

Also Published As

Publication number Publication date
US11566081B2 (en) 2023-01-31
US20200131278A1 (en) 2020-04-30
EP3227681B1 (en) 2020-10-21
US10570216B2 (en) 2020-02-25
EP3227681A2 (en) 2017-10-11
WO2016090163A2 (en) 2016-06-09
AU2021215156A1 (en) 2021-09-02
WO2016090163A3 (en) 2016-08-25
JP2020189843A (ja) 2020-11-26
AU2015358373B2 (en) 2021-05-27
JP7072022B2 (ja) 2022-05-19
JP2017538786A (ja) 2017-12-28
EP3227681A4 (en) 2018-06-13
JP6785239B2 (ja) 2020-11-18
US20170362340A1 (en) 2017-12-21
AU2015358373A1 (en) 2017-05-25
AU2015358373A9 (en) 2021-05-27
CA2967037A1 (en) 2016-06-09

Similar Documents

Publication Publication Date Title
ES3001985T3 (en) Improved methods of assessing uch-l1 in patient samples
JP7072022B2 (ja) 抗アセトアミノフェン抗体及びアセトアミノフェンタンパク質付加物
CN110546513A (zh) 使用早期生物标记物帮助超急性诊断和确定人类受试者中的创伤性脑损伤的方法
CN111094983A (zh) 使用胶质细胞原纤维酸性蛋白(gfap)和/或泛素羧基末端水解酶l1(uch-l1)帮助诊断和评价已遭受骨科损伤并已遭受或可能已遭受头部损伤诸如轻度创伤性脑损伤(tbi)的患者的方法
CA2947660A1 (en) Anti-b7-h3 antibodies and diagnostic uses thereof
JPWO2020158856A1 (ja) 生物学的試料中の遊離ａｉｍの免疫学的分析方法
ES2754282T3 (es) Aductos acetaminofén proteína y procedimientos de uso de los mismos
CA2967037C (en) Anti-acetaminophen antibodies and acetaminophen protein adducts
HK1242422A1 (en) Anti-acetaminophen antibodies and acetaminophen protein adducts
HK1242422B (en) Anti-acetaminophen antibodies and acetaminophen protein adducts
US10060925B2 (en) Miox antibody and assay
ES2704120T3 (es) Miositis
CN117751288A (zh) 评价儿科受试者的脑损伤的方法
CN120188044A (zh) 用于区分轻度创伤性脑损伤与超轻度创伤性脑损伤的生物标志物和方法
CN118715440A (zh) 诊断脑损伤的方法和系统
CN118591730A (zh) 诊断脑损伤的方法和系统
JPWO2012077643A1 (ja) ｃｏｆｉｌｉｎ１タンパク質の免疫学的測定方法
EP4217744A1 (en) Methods for determining a level of a cell fragment-bound complement activation product
HK40029684A (en) Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
HK40015192A (en) Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
HK40020584A (en) Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
HK40012576A (en) Improved methods of assessing gfap status in patient samples
JP2012131713A (ja) ヒトｄａｐｉｔを免疫原として得られたポリクローナル抗体
JP2012184210A (ja) ヒトｍｌｑを免疫原として得られたポリクローナル抗体